Tower Research Capital LLC (Trc) Global Blood Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$32.4 - $68.18 $39,236 - $82,565	-1,211 Reduced 8.08%	13,771 $938,000
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $158,842 - $266,328	7,123 Added 90.63%	14,982 $479,000
Q1 2022 May 12, 2022	BUY	$25.68 - $35.59 $14,432 - $20,001	562 Added 7.7%	7,859 $273,000
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $33,963 - $54,914	-1,364 Reduced 15.75%	7,297 $213,000
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $155,224 - $227,475	6,092 Added 237.14%	8,661 $221,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $59,791 - $79,979	1,842 Added 253.37%	2,569 $90,000
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $470,862 - $614,878	-12,092 Reduced 94.33%	727 $30,000
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $399,315 - $676,344	10,606 Added 479.26%	12,819 $555,000
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $689,256 - $973,137	-13,064 Reduced 85.51%	2,213 $122,000
Q2 2020 Aug 13, 2020	BUY	$48.73 - $81.82 $744,448 - $1.25 Million	15,277 New	15,277 $964,000
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $203,927 - $426,233	-4,888 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$45.7 - $81.86 $123,984 - $222,086	2,713 Added 124.74%	4,888 $389,000
Q3 2019 Nov 05, 2019	SELL	$45.35 - $57.91 $57,367 - $73,256	-1,265 Reduced 36.77%	2,175 $106,000
Q2 2019 Aug 13, 2019	BUY	$52.6 - $63.29 $175,578 - $211,262	3,338 Added 3272.55%	3,440 $181,000
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $30,312 - $40,537	-758 Reduced 88.14%	102 $5,000
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $24,065 - $35,609	-763 Reduced 47.01%	860 $35,000
Q3 2018 Nov 13, 2018	BUY	$38.0 - $51.1 $16,606 - $22,330	437 Added 36.85%	1,623 $62,000
Q2 2018 Aug 15, 2018	SELL	$38.7 - $50.15 $10,874 - $14,092	-281 Reduced 19.15%	1,186 $54,000
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $17,622 - $29,325	445 Added 43.54%	1,467 $71,000
Q4 2017 Feb 09, 2018	BUY	$29.7 - $45.7 $28,363 - $43,643	955 Added 1425.37%	1,022 $40,000
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $1,681 - $2,080	67	67 $2,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account